Address
Email address
Phone number
We offer top quality molecular biology reagents that are all stable at room temperature!
Name
Solis US Invest OÜ
Registry code
11378730
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
08.06.2007 (17)
Financial year
01.01-31.12
Capital
10 000.00 €
Activity
64201 - Activities of holding companies
3 237 687 €
-675 691 €
-21%
3 300 €
(estimate is approximate)
2 515 225 €
45
Submitted
No tax arrears
-27%
-11%
Owner | Representative | Beneficial owner | Roles | |
---|---|---|---|---|
Olev Kahre 06.10.1965 (59) | 60% - 6 000.00 EUR | Board member | Direct ownership | Founder |
Kadri Artma 23.04.1970 (54) | 40% - 4 000.00 EUR | Board member | Direct ownership | |
Agu Artma 05.02.1967 (57) | - | - | - | Founder |
Owner | Representative | Beneficial owner | Roles | |
---|---|---|---|---|
NOBISOL Technologies OÜ 11106026 | 100% - 2 560.00 EUR | - | - | |
SBD Capital OÜ 16246111 | 100% - 2 500.00 EUR | - | - | Founder |
Solis BioDyne OÜ 10242922 | 100% - 10 000.00 EUR | - | - |
2019 18.10.2020 | 2020 29.04.2021 | 2021 23.04.2022 | 2022 07.05.2023 | 2023 03.05.2024 | |
---|---|---|---|---|---|
Total Revenue | - | - | 8 509 793 € | 6 137 990 € | 3 237 687 € |
Net profit (loss) for the period | 789 478 € | 3 665 676 € | 3 280 416 € | 1 115 623 € | -675 691 € |
Profit Margin | - | - | 39% | 18% | -21% |
Current Assets | 1 364 € | 10 075 € | 4 871 871 € | 3 072 719 € | 2 540 822 € |
Fixed Assets | 1 654 023 € | 4 420 132 € | 2 741 166 € | 3 894 459 € | 3 730 699 € |
Total Assets | 1 655 387 € | 4 430 207 € | 7 613 037 € | 6 967 178 € | 6 271 521 € |
Current Liabilities | 13 630 € | 15 330 € | 1 800 559 € | 2 596 413 € | 2 731 501 € |
Non Current Liabilities | - | - | 737 185 € | 1 179 849 € | 1 024 795 € |
Total Liabilities | - | - | 2 537 744 € | 3 776 262 € | 3 756 296 € |
Share Capital | - | - | - | - | - |
Equity | 1 641 757 € | 4 414 877 € | 5 075 293 € | 3 190 916 € | 2 515 225 € |
Employees | 0 | 0 | 56 | 62 | 45 |
Turnover | State taxes | Labor taxes and payments | Employees | |
---|---|---|---|---|
2023 Q2 | - | 5 519.07 € | 5 268.82 € | - |
2022 Q2 | - | 70 000 € | 70 000 € | - |
2021 Q2 | - | 41 300 € | 41 300 € | - |
2020 Q2 | - | 20 300 € | 20 300 € | - |